Feasibility of telephone follow-up after medical abortion

Contraception

Volumn 81, Issue 2, 2010, Pages 143-149

  Perriera, Lisa K ^a   Reeves, Matthew F ^a,b   Chen, Beatrice A ^a   Hohmann, Heather L ^a   Hayes, Jennifer ^a   Creinin, Mitchell D ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Medical abortion; Mifepristone; Misoprostol; Telephone follow up; Urine pregnancy test

Indexed keywords

CHORIONIC GONADOTROPIN; CODEINE; IBUPROFEN; MIFEPRISTONE; MISOPROSTOL; OXYCODONE; PARACETAMOL; RHESUS D ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HOME DIAGNOSTIC TEST; HORMONE BLOOD LEVEL; HUMAN; INCOMPLETE ABORTION; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL ABORTION; PREGNANCY; PREGNANCY TEST; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TELEPHONE; URINALYSIS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TESTS; PROSPECTIVE STUDIES; TELEPHONE; TREATMENT OUTCOME;

EID: 73149109292     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.08.008     Document Type: Article

References (21)

1. Mifeprex Package Insert, Danco Laboratories, July 19. 2005.
2. Schaff E.A., Fielding S.L., Westhoff C., et al. Randomized trial of vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion (<56 days gestation). JAMA 284 (2000) 1948-1953
3. Schaff E.A., Fielding S.L., and Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 64 (2001) 81-85
4. Fiala C., Safar P., Bygdeman M., and Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol 109 (2003) 190-195
5. Godfrey E.M., Anderson A., Fielding S.L., and Creinin M.D. Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. Contraception 75 (2007) 378-382
6. Reeves M.F., Fox M.C., Lohr P.A., and Creinin M.D. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol 34 (2009) 104-109
7. Benson J., Clark K.A., Gerhardt A., Randall L., and Dudley S. Early abortion services in the United States: a provider survey. Contraception 67 (2003) 287-294
8. Joffe C. Reactions to medical abortion among providers of surgical abortion: an early snapshot. Fam Plann Perspect 31 (1999) 35-38
9. Creinin M.D. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol. Am J Obstet Gynecol 174 (1996) 776-778
10. Walker K., Schaff E., Fielding S., and Fuller L. Monitoring serum chorionic gonadotropin levels after mifepristone abortion. Contraception 64 (2001) 271-273
11. Creinin M.D., and Vittinghoff E. Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial. JAMA 272 (1994) 1190-1195
12. Schaff E.A., Eisinger S.H., Franks P., and Kim S.S. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 4 (1995) 774-779
13. Pymar H.C., Creinin M.D., and Schwartz J.L. Mifepristone followed on the same day by vaginal misoprostol for early abortion. Contraception 64 (2001) 87-92
14. Rossi B., Creinin M.D., and Meyn L.A. The ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception 70 (2004) 313-317
15. Lohr P., Reeves M., Hayes J., Harwood B., and Creinin M. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study. Contraception 76 (2007) 215-220
16. Creinin M.D., Fox M., Teal S., Chen A., Schaff E., and Meyn L.A. Randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103 (2004) 851-859
17. Winikoff B., Dzuba I.G., Creinin M.D., et al. Two distinct oral routes of misoprostol in mifepristone medical abortion. Obstet Gynecol 112 6 (2008) 1303-1310
18. Creinin M.D., Schreiber C.A., Bednarek P., Lintu H., Wagner M.S., and Meyn L. Mifepristone and misoprostol administered simultaneously compared with 24 hours apart for abortion. Obstet Gynecol 109 (2007) 885-894
19. Von Hertzen H., Honkanen H., Piaggio G., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion I: efficacy. Br J Obstet Gynecol 110 (2003) 808-818
20. Creinin M.D., Potter C., Holovanisin S., et al. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. Am J Obstet Gynecol 188 3 (2003) 664-669
21. Schaff E., Fielding S., Eisinger S., Stadalius L., and Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61 (2000) 41-46